About THERYQ
Located in the South of France, THERYQ is an innovative medical technology company specializing in the design and production of radiotherapy machines incorporating linear accelerators. The company masters and provides essential expertise on project management, R&D, industrialization and manufacturing. THERYQ is part of ALCEN For Health, the healthcare branch of the ALCEN group.
The focus of our technology is to translate FLASH radiotherapy from laboratory to clinical practice. Currently in the pre-clinical research stage, our goal is to:
- Develop solutions to increase patients’ opportunities to be cured of cancer
- Decrease direct and indirect treatment costs
- Offer clinicians devices capable of more efficient treatments for improved patient outcomes
THERYQ is a spin-off of the company PMB-ALCEN, which led the pioneering projects on FLASH Radiotherapy since 2013 and has a long-standing collaboration with several prominent institutions around the world. In 2022, PMB transferred the complete branch of activity dedicated to radiotherapy to THERYQ.
EN ISO 13485 Certification
THERYQ is ISO 13485 certified for medical-device manufacturing. Achieving ISO 13485 certification represents a major milestone for us, recognizing that working methods, and expertise meet the international requirements and highest standards of the industry for the development, manufacture, and servicing of medical devices.
Attaining ISO 13485 certification is not only a mark of compliance but also a reflection of our ongoing commitment to continuous improvement, risk management, and delivering solutions that meet international standards and market needs.
